CARL CARLSMED INC revenue, earnings and financials
For the quarter ended June 30, 2026, CARLSMED INC reported revenue of $18.9M (up 56.7% from a year earlier), net income of −$10.5M and diluted EPS of −$0.39; over the last four quarters revenue was $63.3M and net income −$36.3M; for the fiscal year ended December 2025 revenue was $50.5M, up 85.9% on the year before.
CARL annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $50.5M, gross profit $38.0M, operating income −$30.6M, net income −$29.6M (margin -58.7%), EPS −$2.12
- Fiscal year ended Dec 2024: revenue $27.2M, gross profit $20.0M, operating income −$24.1M, net income −$24.3M (margin -89.3%), EPS −$6.11
CARL quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $18.9M (up 56.7% year over year), net income −$10.5M, EPS −$0.39
- Quarter ended Mar 31, 2026: revenue $16.1M (up 58.2% year over year), net income −$8.70M, EPS −$0.32
- Quarter ended Dec 31, 2025 (from the annual report): revenue $15.2M, net income −$8.61M, EPS $1.22
- Quarter ended Sep 30, 2025: revenue $13.1M (up 98.4% year over year), net income −$8.53M, EPS −$0.40
- Quarter ended Jun 30, 2025: revenue $12.1M (up 98.7% year over year), net income −$6.77M, EPS −$1.47
- Quarter ended Mar 31, 2025: revenue $10.2M, net income −$5.73M, EPS −$1.47
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$4.72M, EPS n/a
- Quarter ended Sep 30, 2024: revenue $6.59M, net income −$7.81M, EPS −$2.06
- Quarter ended Jun 30, 2024: revenue $6.08M, net income −$6.28M, EPS −$1.55
- Quarter ended Mar 31, 2024: revenue n/a, net income −$5.45M, EPS n/a
CARL cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$29.0M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$25.5M, share buybacks n/a
CARL balance sheet
- Jun 30, 2026: cash $46.2M, total assets $118M, total liabilities $34.0M, shareholders' equity $84.2M
- Mar 31, 2026: cash $73.0M, total assets $119M, total liabilities $26.5M, shareholders' equity $92.2M
- Dec 31, 2025: cash $85.8M, total assets $130M, total liabilities $31.3M, shareholders' equity $98.9M
- Sep 30, 2025: cash $115M, total assets $135M, total liabilities $28.2M, shareholders' equity $107M
- Jun 30, 2025: cash $33.5M, total assets $53.3M, total liabilities $27.6M, shareholders' equity −$83.1M
- Dec 31, 2024: cash $40.1M, total assets $51.8M, total liabilities $26.2M, shareholders' equity −$70.6M
What is CARL's revenue?
CARLSMED INC reported $63.3M of revenue over its last four quarters, through June 30, 2026.
Is CARL profitable?
No. CARLSMED INC lost $36.3M over the last four quarters.
What is CARL's EPS?
Diluted earnings per share over the last four quarters were $0.11; −$0.39 in the latest quarter.